Is GenMont Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, GenMont Biotech pays dividends. Last time was Wednesday 10th of July 2024 where the investors holding the stock on Monday 17th of June 2024 were paid TWD0.5 per share. Over the last 11 times between 2009 and 2024, GenMont Biotech has paid TWD10.50918 with an average of TWD0.96 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for GenMont Biotech 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was TWD26.00, you would have made a loss of TWD-3.10 per share or -11.92%
Yes, the average daily trading liquidity for GenMont Biotech is TWD63 559 thousand. You should therefore be able to get in and out of your positions relatively fast.
GenMont Biotech has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.10, the company's ability to pay off the debt is good. GenMont Biotech has a good net profit margin of 16.77% and should have high tolerances against inflation.
We have calculated the inflation risk for GenMont Biotech to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.